These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18283864)

  • 1. [Transfusion-transmitted diseases].
    Shimoyama R
    Hokkaido Igaku Zasshi; 2008 Jan; 83(1):5-21. PubMed ID: 18283864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-transmitted infections: existing and emerging pathogens.
    Kaur P; Basu S
    J Postgrad Med; 2005; 51(2):146-51. PubMed ID: 16006714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections.
    Tani Y; Aso H; Matsukura H; Tadokoro K; Tamori A; Nishiguchi S; Yoshizawa H; Shibata H;
    Vox Sang; 2012 May; 102(4):285-93. PubMed ID: 22082342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging issues in blood safety.
    Chamberland M; Khabbaz RF
    Infect Dis Clin North Am; 1998 Mar; 12(1):217-29. PubMed ID: 9494840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
    Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ
    N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
    Corash L
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risks to donor and recipient in blood collection and blood transfusion].
    Bergmann H
    Infusionsther Klin Ernahr; 1977 Apr; 4(2):84-6. PubMed ID: 558163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-transmitted infectious diseases.
    Allain JP; Stramer SL; Carneiro-Proietti AB; Martins ML; Lopes da Silva SN; Ribeiro M; Proietti FA; Reesink HW
    Biologicals; 2009 Apr; 37(2):71-7. PubMed ID: 19231236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to minimize infection risk in blood banking and transfusion practice.
    Lindholm PF; Annen K; Ramsey G
    Infect Disord Drug Targets; 2011 Feb; 11(1):45-56. PubMed ID: 21303341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C; Araújo F
    Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
    Pillonel J; Laperche S; ; ;
    Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reacting to an emerging safety threat: West Nile virus in North America.
    Stramer SL
    Dev Biol (Basel); 2007; 127():43-58. PubMed ID: 17486880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of infections transmissible by blood derivatives.
    Barbara JA
    Transfus Sci; 1998 Mar; 19(1):3-7. PubMed ID: 10182180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-transmitted infections.
    Bihl F; Castelli D; Marincola F; Dodd RY; Brander C
    J Transl Med; 2007 Jun; 5():25. PubMed ID: 17553144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update on infectious risks associated with blood products].
    Traineau R; Elghouzzi MH; Bierling P
    Rev Prat; 2009 Jan; 59(1):86-9. PubMed ID: 19253889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.